pd 169316 has been researched along with Autosomal Dominant Juvenile Parkinson Disease in 1 studies
2-(4-nitrophenyl)-4-(4-fluorophenyl)-5-(4-pyridinyl)-1H-imidazole: p38 MAP kinase inhibitor
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zawada, WM | 1 |
| Meintzer, MK | 1 |
| Rao, P | 1 |
| Marotti, J | 1 |
| Wang, X | 1 |
| Esplen, JE | 1 |
| Clarkson, ED | 1 |
| Freed, CR | 1 |
| Heidenreich, KA | 1 |
1 other study available for pd 169316 and Autosomal Dominant Juvenile Parkinson Disease
| Article | Year |
|---|---|
Inhibitors of p38 MAP kinase increase the survival of transplanted dopamine neurons.
Topics: Animals; Brain Tissue Transplantation; Cell Survival; Cells, Cultured; Dopamine; Enzyme Inhibitors; | 2001 |